Cutler Group LP Bio Xcel Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 07, 2023	SELL	$2.49 - $11.85 $996 - $4,740	-400 Reduced 9.09%	4,000 $50,000
Q2 2023 Jul 18, 2023	BUY	$6.39 - $28.58 $28,116 - $125,751	4,400 New	4,400 $40,000
Q1 2022 Apr 14, 2022	BUY	$15.0 - $22.83 $39,000 - $59,357	2,600 Added 2600.0%	2,700 $0
Q3 2021 Oct 26, 2021	SELL	$23.84 - $32.03 $7,152 - $9,609	-300 Reduced 75.0%	100 $1,000
Q1 2021 Apr 26, 2021	SELL	$39.04 - $64.6 $42,944 - $71,060	-1,100 Reduced 73.33%	400 $1,000
Q4 2020 Jan 21, 2021	SELL	$42.46 - $56.58 $416,108 - $554,484	-9,800 Reduced 86.73%	1,500 $10,000
Q3 2020 Oct 27, 2020	BUY	$37.44 - $64.63 $269,568 - $465,335	7,200 Added 175.61%	11,300 $27,000
Q2 2020 Jul 22, 2020	SELL	$17.62 - $58.71 $40,526 - $135,033	-2,300 Reduced 35.94%	4,100 $14,000
Q1 2020 May 07, 2020	BUY	$12.26 - $41.14 $78,464 - $263,296	6,400 New	6,400 $42,000

502K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $47.9M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.